Development of Cr2+-Doped II-VI Heterostructure Laser Grown by Molecular Beam Epitaxy for Room-Temperature Infrared Applications
用于室温红外应用的分子束外延生长的 Cr2 掺杂 II-VI 异质结构激光器的开发
基本信息
- 批准号:0070015
- 负责人:
- 金额:$ 29.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Continuing Grant
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-06-01 至 2004-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
A compact infrared tunable room-temperature optically-pumped semiconductor laser source using epitaxially-grown transition metal-doped II-VI materials is proposed. Chromium-doped II-VI lasers have already been demonstrated using ZnS, ZnSe, CdTe, CdMnTe, and CdSe with other semiconductor hosts under investigation. Current Cr2+ lasers are relatively simple structures, presently Cr-doped bulk crystals, that operate at room temperature and are tunable over a large wavelength range (~ 2.1mm-2.8mm) with relatively temperature-insensitive operating characteristics. To achieve better performance, we propose the use of epitaxial II-VI heterostructures that will be composed of alloys of Zn1-xMgxSe and Zn1-xCdxSe grown by MBE, rather than homostructures. The II-VI waveguide laser structure with Cr-doped active layer will be grown on a GaAs substrate. Such heterostructures will confine the radiation emitted by Cr2+ to the active region, increasing the optical confinement factor. The waveguide structure may also be used to increase the optical overlap of the pump source and the optically-active Cr2+. These heterostructures will have a greatly reduced lasing threshold and increased overall efficiency as compared to the homostructures. The epitaxial structures will be characterized via photoluminescence and electron paramagnetic resonance spectroscopy. An optically-pumped Cr-doped heterostructure laser will be demonstrated using a commercially-available semiconductor laser pump.
利用外延生长过渡金属掺杂的II-VI材料,提出了一种紧凑的室温红外可调谐光泵浦半导体激光源。掺杂铬的II-VI激光器已经被证明使用ZnS, ZnSe, CdTe, CdMnTe和CdSe与其他正在研究的半导体主体。目前的Cr2+激光器是相对简单的结构,目前是掺cr的块状晶体,在室温下工作,可在大波长范围(~ 2.1mm-2.8mm)内调谐,具有相对温度不敏感的工作特性。为了获得更好的性能,我们建议使用由MBE生长的Zn1-xMgxSe和Zn1-xCdxSe合金组成的外延II-VI异质结构,而不是同质结构。在GaAs衬底上生长了掺杂cr有源层的II-VI波导激光器结构。这种异质结构将Cr2+发射的辐射限制在有源区域,增加了光学约束因子。波导结构还可用于增加泵浦源和光学活性Cr2+的光学重叠。与同质结构相比,这些异质结构将大大降低激光阈值并提高整体效率。外延结构将通过光致发光和电子顺磁共振谱来表征。光泵浦掺铬异质结构激光器将演示使用商用半导体激光泵浦。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Thomas Myers其他文献
Treatment approaches for three shoulder ‘tethers’
- DOI:
10.1016/j.jbmt.2006.09.003 - 发表时间:
2007-01-01 - 期刊:
- 影响因子:
- 作者:
Thomas Myers - 通讯作者:
Thomas Myers
A Novel Metal-Rich Anneal for In Vacuo Passivation of High-Aspect-Ratio Mercury Cadmium Telluride Surfaces
- DOI:
10.1007/s11664-013-2818-2 - 发表时间:
2013-10-08 - 期刊:
- 影响因子:2.500
- 作者:
Chang-Feng Wan;Thomas Orent;Thomas Myers;Ishwara Bhat;Andy Stoltz;Joe Pellegrino - 通讯作者:
Joe Pellegrino
Correction to: Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
- DOI:
10.1007/s10549-019-05218-8 - 发表时间:
2019-04-15 - 期刊:
- 影响因子:3.000
- 作者:
Jangsoon Lee;Bora Lim;Troy Pearson;Kuicheon Choi;Jon A. Fuson;Chandra Bartholomeusz;Linda J. Paradiso;Thomas Myers;Debu Tripathy;Naoto T. Ueno - 通讯作者:
Naoto T. Ueno
Aurora Kinase a Inhibition for Gvhd and Relapse Prevention after Allogeneic HCT: Phase I Trial in Combination with Ptcy/Sirolimus
- DOI:
10.1182/blood-2023-181292 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Shernan G. Holtan;Kelly Walton;Najla H El Jurdi;Joseph E. Maakaron;Mark Juckett;Veronika Bachanova;Thomas Myers;Linda J. Paradiso;Todd DeFor;Qing Cao;Brian Betts - 通讯作者:
Brian Betts
IMPACT OF MEDICAL VERSUS SURGICAL MANAGEMENT OF A HEMODYNAMICALLY SIGNIFICANT PATENT DUCTUS ARTERIOSUS (HSPDA) IN LOW BIRTH WEIGHT NEWBORNS. 1375
低出生体重新生儿有血液动力学意义的动脉导管未闭(HSPDA)的医疗管理与手术管理的影响。1375
- DOI:
10.1203/00006450-199604001-01398 - 发表时间:
1996-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Jonathan Muraskas;Marc Weiss;Janice Poulos;Frank Cetta;Nancy LaMear;Thomas Myers - 通讯作者:
Thomas Myers
Thomas Myers的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Thomas Myers', 18)}}的其他基金
A Coordinated Experimental and Computational Modeling Investigation of Native Defects in Undoped, Nitrogen-Doped and Chlorine-Doped ZnSe and ZnMgSe Alloys Grown by Molecular..
分子生长的未掺杂、氮掺杂和氯掺杂 ZnSe 和 ZnMgSe 合金中固有缺陷的协调实验和计算模型研究
- 批准号:
9806299 - 财政年份:1998
- 资助金额:
$ 29.64万 - 项目类别:
Continuing Grant
Acquisition of a Custom Molecular Beam Epitaxy System
获得定制分子束外延系统
- 批准号:
9208130 - 财政年份:1992
- 资助金额:
$ 29.64万 - 项目类别:
Standard Grant
Research in Undergraduate Institutions: Acquisition of an Electroreflectance Spectrometer (Materials Research)
本科院校研究:购置电反射光谱仪(材料研究)
- 批准号:
8420693 - 财政年份:1985
- 资助金额:
$ 29.64万 - 项目类别:
Standard Grant
Transformations on Conditional Rewriting Systems
条件重写系统的转换
- 批准号:
8113250 - 财政年份:1982
- 资助金额:
$ 29.64万 - 项目类别:
Standard Grant
Onshore Impacts of Offshore Oil and Gas: Methodology Development and Test
海上石油和天然气对陆上的影响:方法开发和测试
- 批准号:
7622611 - 财政年份:1976
- 资助金额:
$ 29.64万 - 项目类别:
Contract
相似国自然基金
Cr2+:ZnSe中红外增益薄膜的生长及发光特性研究
- 批准号:61905169
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
具有稀土敏化特性的Cr2+:II-VI纳晶/硫系玻璃复合光纤可控制备及其关键性能研究
- 批准号:51872055
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
拓扑绝缘体用于Cr2+:ZnSe激光器锁模的研究
- 批准号:61405126
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
镶嵌ZnS(ZnSe): Cr2+纳米晶的硫系光纤及其中红外发光研究
- 批准号:61405080
- 批准年份:2014
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
Cr2+,Fe2+掺杂的II-VI晶体中红外激光器研究
- 批准号:61275142
- 批准年份:2012
- 资助金额:90.0 万元
- 项目类别:面上项目
相似海外基金
Complement and CR2/CD21 in the Immune Pathogenesis of HIT
HIT 免疫发病机制中的补体和 CR2/CD21
- 批准号:
10077790 - 财政年份:2018
- 资助金额:
$ 29.64万 - 项目类别:
Disconnecting CR2/CD21 from Its C3d Ligand to Ameliorate Lupus
断开 CR2/CD21 与其 C3d 配体的连接以改善狼疮
- 批准号:
8492301 - 财政年份:2013
- 资助金额:
$ 29.64万 - 项目类别:
Regulation of CR2/CD21 Expression and Activation
CR2/CD21 表达和激活的调节
- 批准号:
7880369 - 财政年份:2009
- 资助金额:
$ 29.64万 - 项目类别:
En route to broadly tunable middle-infrared optically and electrically pumpable Cr2+ and Fe2+ doped II-VI semiconductor lasers
致力于广泛可调谐中红外光学和电泵浦 Cr2 和 Fe2 掺杂 II-VI 半导体激光器
- 批准号:
0424310 - 财政年份:2005
- 资助金额:
$ 29.64万 - 项目类别:
Standard Grant
Transcriptional regulation of the Complement Receptor 2 gene (CR2/CD21) during B cell lineage committment
B 细胞谱系定型过程中补体受体 2 基因 (CR2/CD21) 的转录调控
- 批准号:
nhmrc : 303206 - 财政年份:2004
- 资助金额:
$ 29.64万 - 项目类别:
NHMRC Project Grants